Anti-thrombin III Testing Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: AC6E0B6DDB04EN
Market Monitor Global

Abstracts

Antithrombin (AT, Antithrombin III, ATIII) is a small glycoprotein produced by the liver that inactivates several enzymes of the coagulation system.

This report contains market size and forecasts of Anti-thrombin III Testing in Global, including the following market information:

Global Anti-thrombin III Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Anti-thrombin III Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Diagnosis of antithrombin deficiency Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-thrombin III Testing include Abbott Laboratories, Danaher Corp., F. Hoffmann-La Roche Ltd., Siemens Healthcare GmbH and Thermo Fisher Scientific Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-thrombin III Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-thrombin III Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Anti-thrombin III Testing Market Segment Percentages, by Type, 2021 (%)

• Diagnosis of antithrombin deficiency
• Activity assays
• Immunological assays

Global Anti-thrombin III Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Anti-thrombin III Testing Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Research institute
• Clinic
• Other

Global Anti-thrombin III Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Anti-thrombin III Testing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-thrombin III Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Anti-thrombin III Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• Danaher Corp.
• F. Hoffmann-La Roche Ltd.
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-thrombin III Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-thrombin III Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-THROMBIN III TESTING OVERALL MARKET SIZE

2.1 Global Anti-thrombin III Testing Market Size: 2021 VS 2028
2.2 Global Anti-thrombin III Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Anti-thrombin III Testing Players in Global Market
3.2 Top Global Anti-thrombin III Testing Companies Ranked by Revenue
3.3 Global Anti-thrombin III Testing Revenue by Companies
3.4 Top 3 and Top 5 Anti-thrombin III Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anti-thrombin III Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-thrombin III Testing Players in Global Market
  3.6.1 List of Global Tier 1 Anti-thrombin III Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Anti-thrombin III Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Anti-thrombin III Testing Market Size Markets, 2021 & 2028
  4.1.2 Diagnosis of antithrombin deficiency
  4.1.3 Activity assays
  4.1.4 Immunological assays
4.2 By Type - Global Anti-thrombin III Testing Revenue & Forecasts
  4.2.1 By Type - Global Anti-thrombin III Testing Revenue, 2017-2022
  4.2.2 By Type - Global Anti-thrombin III Testing Revenue, 2023-2028
  4.2.3 By Type - Global Anti-thrombin III Testing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-thrombin III Testing Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Research institute
  5.1.4 Clinic
  5.1.5 Other
5.2 By Application - Global Anti-thrombin III Testing Revenue & Forecasts
  5.2.1 By Application - Global Anti-thrombin III Testing Revenue, 2017-2022
  5.2.2 By Application - Global Anti-thrombin III Testing Revenue, 2023-2028
  5.2.3 By Application - Global Anti-thrombin III Testing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti-thrombin III Testing Market Size, 2021 & 2028
6.2 By Region - Global Anti-thrombin III Testing Revenue & Forecasts
  6.2.1 By Region - Global Anti-thrombin III Testing Revenue, 2017-2022
  6.2.2 By Region - Global Anti-thrombin III Testing Revenue, 2023-2028
  6.2.3 By Region - Global Anti-thrombin III Testing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Anti-thrombin III Testing Revenue, 2017-2028
  6.3.2 US Anti-thrombin III Testing Market Size, 2017-2028
  6.3.3 Canada Anti-thrombin III Testing Market Size, 2017-2028
  6.3.4 Mexico Anti-thrombin III Testing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Anti-thrombin III Testing Revenue, 2017-2028
  6.4.2 Germany Anti-thrombin III Testing Market Size, 2017-2028
  6.4.3 France Anti-thrombin III Testing Market Size, 2017-2028
  6.4.4 U.K. Anti-thrombin III Testing Market Size, 2017-2028
  6.4.5 Italy Anti-thrombin III Testing Market Size, 2017-2028
  6.4.6 Russia Anti-thrombin III Testing Market Size, 2017-2028
  6.4.7 Nordic Countries Anti-thrombin III Testing Market Size, 2017-2028
  6.4.8 Benelux Anti-thrombin III Testing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Anti-thrombin III Testing Revenue, 2017-2028
  6.5.2 China Anti-thrombin III Testing Market Size, 2017-2028
  6.5.3 Japan Anti-thrombin III Testing Market Size, 2017-2028
  6.5.4 South Korea Anti-thrombin III Testing Market Size, 2017-2028
  6.5.5 Southeast Asia Anti-thrombin III Testing Market Size, 2017-2028
  6.5.6 India Anti-thrombin III Testing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Anti-thrombin III Testing Revenue, 2017-2028
  6.6.2 Brazil Anti-thrombin III Testing Market Size, 2017-2028
  6.6.3 Argentina Anti-thrombin III Testing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Anti-thrombin III Testing Revenue, 2017-2028
  6.7.2 Turkey Anti-thrombin III Testing Market Size, 2017-2028
  6.7.3 Israel Anti-thrombin III Testing Market Size, 2017-2028
  6.7.4 Saudi Arabia Anti-thrombin III Testing Market Size, 2017-2028
  6.7.5 UAE Anti-thrombin III Testing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Anti-thrombin III Testing Major Product Offerings
  7.1.4 Abbott Laboratories Anti-thrombin III Testing Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 Danaher Corp.
  7.2.1 Danaher Corp. Corporate Summary
  7.2.2 Danaher Corp. Business Overview
  7.2.3 Danaher Corp. Anti-thrombin III Testing Major Product Offerings
  7.2.4 Danaher Corp. Anti-thrombin III Testing Revenue in Global Market (2017-2022)
  7.2.5 Danaher Corp. Key News
7.3 F. Hoffmann-La Roche Ltd.
  7.3.1 F. Hoffmann-La Roche Ltd. Corporate Summary
  7.3.2 F. Hoffmann-La Roche Ltd. Business Overview
  7.3.3 F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Major Product Offerings
  7.3.4 F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Revenue in Global Market (2017-2022)
  7.3.5 F. Hoffmann-La Roche Ltd. Key News
7.4 Siemens Healthcare GmbH
  7.4.1 Siemens Healthcare GmbH Corporate Summary
  7.4.2 Siemens Healthcare GmbH Business Overview
  7.4.3 Siemens Healthcare GmbH Anti-thrombin III Testing Major Product Offerings
  7.4.4 Siemens Healthcare GmbH Anti-thrombin III Testing Revenue in Global Market (2017-2022)
  7.4.5 Siemens Healthcare GmbH Key News
7.5 Thermo Fisher Scientific Inc.
  7.5.1 Thermo Fisher Scientific Inc. Corporate Summary
  7.5.2 Thermo Fisher Scientific Inc. Business Overview
  7.5.3 Thermo Fisher Scientific Inc. Anti-thrombin III Testing Major Product Offerings
  7.5.4 Thermo Fisher Scientific Inc. Anti-thrombin III Testing Revenue in Global Market (2017-2022)
  7.5.5 Thermo Fisher Scientific Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Anti-thrombin III Testing Market Opportunities & Trends in Global Market
Table 2. Anti-thrombin III Testing Market Drivers in Global Market
Table 3. Anti-thrombin III Testing Market Restraints in Global Market
Table 4. Key Players of Anti-thrombin III Testing in Global Market
Table 5. Top Anti-thrombin III Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anti-thrombin III Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anti-thrombin III Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anti-thrombin III Testing Product Type
Table 9. List of Global Tier 1 Anti-thrombin III Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-thrombin III Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-thrombin III Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anti-thrombin III Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anti-thrombin III Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anti-thrombin III Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anti-thrombin III Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anti-thrombin III Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anti-thrombin III Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anti-thrombin III Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anti-thrombin III Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anti-thrombin III Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anti-thrombin III Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anti-thrombin III Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anti-thrombin III Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anti-thrombin III Testing Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Anti-thrombin III Testing Product Offerings
Table 32. Abbott Laboratories Anti-thrombin III Testing Revenue (US$, Mn), (2017-2022)
Table 33. Danaher Corp. Corporate Summary
Table 34. Danaher Corp. Anti-thrombin III Testing Product Offerings
Table 35. Danaher Corp. Anti-thrombin III Testing Revenue (US$, Mn), (2017-2022)
Table 36. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 37. F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Product Offerings
Table 38. F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Revenue (US$, Mn), (2017-2022)
Table 39. Siemens Healthcare GmbH Corporate Summary
Table 40. Siemens Healthcare GmbH Anti-thrombin III Testing Product Offerings
Table 41. Siemens Healthcare GmbH Anti-thrombin III Testing Revenue (US$, Mn), (2017-2022)
Table 42. Thermo Fisher Scientific Inc. Corporate Summary
Table 43. Thermo Fisher Scientific Inc. Anti-thrombin III Testing Product Offerings
Table 44. Thermo Fisher Scientific Inc. Anti-thrombin III Testing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Anti-thrombin III Testing Segment by Type in 2021
Figure 2. Anti-thrombin III Testing Segment by Application in 2021
Figure 3. Global Anti-thrombin III Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-thrombin III Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-thrombin III Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-thrombin III Testing Revenue in 2021
Figure 8. By Type - Global Anti-thrombin III Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anti-thrombin III Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anti-thrombin III Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anti-thrombin III Testing Revenue Market Share, 2017-2028
Figure 12. US Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anti-thrombin III Testing Revenue Market Share, 2017-2028
Figure 16. Germany Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anti-thrombin III Testing Revenue Market Share, 2017-2028
Figure 24. China Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anti-thrombin III Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anti-thrombin III Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anti-thrombin III Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Anti-thrombin III Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Danaher Corp. Anti-thrombin III Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Siemens Healthcare GmbH Anti-thrombin III Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Thermo Fisher Scientific Inc. Anti-thrombin III Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)